MSL stands for Medical Science Liaison, a specialized role within pharmaceutical, biotechnology, and medical device companies. MSLs serve as the scientific bridge between these companies and the healthcare professionals who prescribe or use their products. Unlike sales representatives, MSLs are non-promotional. Their job is to share accurate, unbiased scientific and medical information with doctors, researchers, and other clinicians.
What an MSL Actually Does
An MSL sits within a company’s Medical Affairs department, which is deliberately kept separate from the commercial (sales and marketing) side of the business. Their core responsibilities center on three things: exchanging scientific data with healthcare professionals, supporting the generation of clinical evidence, and gathering insights from the field that inform how a company develops or positions its products.
In practice, this means an MSL might spend a week presenting new clinical trial results to a group of specialists, answering a physician’s detailed questions about a therapy’s mechanism of action, or identifying gaps in how a disease is currently treated. They deliver scientific presentations on disease areas, treatment options, unmet medical needs, and emerging clinical evidence. The role exists in pharmaceutical companies, biotech firms, medical device manufacturers, and contract research organizations.
How MSLs Differ From Sales Reps
This distinction matters, and companies take it seriously. MSLs operate under strict compliance rules that prohibit them from engaging in any promotional activity. They cannot discuss off-label uses of a drug during introductory meetings, they cannot factor a doctor’s prescribing habits into their work, and they cannot share specific details of their conversations with a company’s commercial team. If a discussion with a physician veers into commercial territory, the MSL is expected to leave the room.
The separation extends to physical spaces. At medical conferences, MSLs cannot meet physicians at the company’s exhibit booth if it’s staffed by sales personnel. Scientific discussions must happen in a designated area staffed only by Medical Affairs team members. An MSL and a sales representative should never jointly visit a healthcare provider, with one narrow exception: an initial introductory meeting limited to exchanging contact information.
Physicians notice the difference. In a survey conducted by the MSL Society, 76% of key opinion leaders said their discussions with MSLs were “more valuable” or “much more valuable” than discussions with sales representatives.
Working With Key Opinion Leaders
A large part of the MSL role revolves around building relationships with key opinion leaders, or KOLs. These are physicians, researchers, and specialists who are recognized experts in their field and whose clinical experience and published work carry influence. MSLs identify these experts based on their reputation in the scientific community, their publication record, and clinical studies that align with the MSL’s therapeutic area. Commercial factors like prescribing volume are explicitly off-limits when selecting KOLs to engage.
These relationships are built through ongoing scientific exchange. KOLs have said that the content they find most valuable from MSLs is scientific updates on new or existing drugs and devices (cited by 49% of KOLs surveyed) and clinical trial data (22%). Most KOL meetings are brief. About 90% of virtual meetings with MSLs last 30 minutes or less, and a majority clock in at just 15 minutes. Since the pandemic, more than half of KOLs prefer a mix of in-person and virtual meetings or exclusively virtual interactions with their MSLs.
Education and Qualifications
MSLs typically hold advanced degrees. The field draws professionals with PhDs, PharmDs, MDs, and other graduate-level credentials in the sciences. A 2012 survey by the American Pharmacists Association found that 37% of MSLs held advanced degrees such as an MA, MS, MBA, or PhD, though the field has become increasingly competitive since then, and advanced scientific training is now a baseline expectation at most companies.
For working MSLs looking to formalize their expertise, the MSL Society offers a board certification credential called the MSL-BC. To qualify, candidates need at least a bachelor’s degree and one year of full-time experience working as an MSL or leading an MSL team. The certification exam costs $450 for MSL Society members and $550 for non-members. It is not available to people trying to break into the field who haven’t yet held the role.
How MSL Performance Is Measured
Measuring the impact of a non-sales role has been an ongoing challenge for the industry. A global survey published in the journal Pharmacy found that 92% of organizations track the number of KOL engagements (in-person, virtual, or by phone) as a core metric. Other commonly tracked numbers include the number of actionable insights submitted (53%) and the number of KOL relationships maintained (51%).
But the field is shifting. When asked what should be measured, 70% of respondents said the quality of KOL relationships matters most, and 67% pointed to the quality of insights gathered from the field. Overall, 52% of organizations now favor mostly qualitative metrics over quantitative ones, while only 7% rely primarily on numbers alone. The trend reflects a growing recognition that counting meetings doesn’t capture whether those meetings actually moved the needle on a physician’s understanding or a company’s scientific strategy.
Regulatory Guardrails
MSL activities are shaped by FDA enforcement policies, particularly around how companies can share scientific information about unapproved (off-label) uses of their products. The FDA issued updated guidance in January 2025 covering firm-initiated communications of scientific information on unapproved uses to prescribing healthcare providers. This guidance has evolved through several iterations since 2009, reflecting how central the question of scientific exchange versus promotion remains in the regulatory landscape.
In practice, this means MSLs can discuss published research and clinical data with physicians, but the information must be accurate, balanced, and not designed to drive prescribing. The line between education and promotion is one that MSLs, their compliance teams, and regulators all watch closely.
MSL Salary and Career Path
The MSL role pays well, reflecting the advanced education and scientific expertise required. Based on data from nearly 1,000 job postings between September 2025 and March 2026, the median MSL salary is $186,375. Mid-level MSLs earn a median of $178,750, while senior MSLs earn around $193,250, with the upper range reaching $373,000. Those who move into MSL management roles see a median salary of $224,000.
Career progression typically moves from individual contributor to senior MSL, then into team leadership or broader Medical Affairs roles such as director of medical affairs, medical director, or head of field medical. Some MSLs transition into adjacent functions like clinical development, health outcomes research, or medical communications.